Dear colleagues, Dear friends,
We would be delighted to welcome you to the next Santorini conference “Systems Medicine Personalised Health and Therapy – The Odyssey from Hope to Practice”, which will take place in Santorini, Greece from September 30th to October 3rd 2018, with special focus on cardio-metabolic diseases and cancer.
The conference will offer to participants a platform to exchange ideas, broaden knowledge, discover novel opportunities, reacquaint with colleagues, meet new friends and create interactions among disciplines, as well as between academic and industrial research, directed around a scientific content towards an effective ‘roadmap’ for personalised health and therapy.
We expect more than 250 international delegates (researchers, scientists, academics, industrials, biologists, pathologists, oncologists, genetic epidemiologists, pharmacogeneticists and biobanking experts) in a creative environment.
To know more about the Conference: http://santoriniconference.org/
Together with its Steering Committee (SC) and Scientific Advisory Board (SAB) with members across academia, clinics and industry, the 9th Santorini Conference will be part of a new era of the Santorini Conferences series.
The goal to facilitate scientific exchange between basic research, industrial research and medical areas has been maintained and strengthened by a sustainable and clearly visible new concept with respect to content, structure, economy and people.
This new conference aims to answer:
- Can genetic screening help identify individuals at greatest risk for cardio-metabolic diseases and cancer?
- What is the greatest clinical need with regard to diagnosis, prediction and patient stratification for these pathologies and how this is/can be addressed?
- Does a genetic risk score identify patients at highest risk and is its use justified in clinical practice?
- What are the challenges of the current clinical trials?
- What about comorbidities with aging?
- What is the impact of pharmacogenomics on:
- Deliverance of more predictable responses to drug therapy
- Minimisation of the occurrence and severity of adverse drug reactions
- Conduction of more cost-effective clinical trials
- Drug discovery and the drug development process
- Do the existing diagnostic tools answer the needs of pharmacogenomics?
As you can see, the scientific programme is well advanced (attached to this newsletter). It also includes 1 session with young researchers’ lectures and posters presentations with the possibility to obtain “Gerard Siest” awards. If you wish to make an oral presentation you must not loose time to submit your abstract, more information will be soon available at: www.santoriniconference.org.
This conference will also be yours and we count a lot on you for being with us in Santorini in 2018 under a nice sun and warm weather that fosters an even more creative atmosphere!
President of the Santorini Conference series
résentation orale ou un poster !